IL188685A0 - Use of 4-(3,4-dichloro-phenyl)-1,2,3,4-tetrahydro-naphtalen-1-ylamine for treating cancer - Google Patents

Use of 4-(3,4-dichloro-phenyl)-1,2,3,4-tetrahydro-naphtalen-1-ylamine for treating cancer

Info

Publication number
IL188685A0
IL188685A0 IL188685A IL18868508A IL188685A0 IL 188685 A0 IL188685 A0 IL 188685A0 IL 188685 A IL188685 A IL 188685A IL 18868508 A IL18868508 A IL 18868508A IL 188685 A0 IL188685 A0 IL 188685A0
Authority
IL
Israel
Prior art keywords
naphtalen
ylamine
tetrahydro
dichloro
phenyl
Prior art date
Application number
IL188685A
Original Assignee
Anceris
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Anceris filed Critical Anceris
Publication of IL188685A0 publication Critical patent/IL188685A0/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/475—Quinolines; Isoquinolines having an indole ring, e.g. yohimbine, reserpine, strychnine, vinblastine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Emergency Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IL188685A 2005-07-12 2008-01-09 Use of 4-(3,4-dichloro-phenyl)-1,2,3,4-tetrahydro-naphtalen-1-ylamine for treating cancer IL188685A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0507480A FR2888506A1 (en) 2005-07-12 2005-07-12 USE OF 4- (3,4-DICHLOROPHENYL) -1,2,3,4-TETRAHYDRO-NAPHTHALEN-1-YLAMINE FOR THE TREATMENT OF CANCER
PCT/EP2006/064155 WO2007006797A1 (en) 2005-07-12 2006-07-12 Use of 4-(3,4-dichloro-phenyl)-1,2,3,4-tetrahydro-naphtalen-1-ylamine for treating cancer

Publications (1)

Publication Number Publication Date
IL188685A0 true IL188685A0 (en) 2008-12-29

Family

ID=35925210

Family Applications (1)

Application Number Title Priority Date Filing Date
IL188685A IL188685A0 (en) 2005-07-12 2008-01-09 Use of 4-(3,4-dichloro-phenyl)-1,2,3,4-tetrahydro-naphtalen-1-ylamine for treating cancer

Country Status (14)

Country Link
EP (1) EP1904045A1 (en)
JP (1) JP2009501193A (en)
KR (1) KR20080031748A (en)
CN (1) CN101222917A (en)
AU (1) AU2006268657A1 (en)
CA (1) CA2614696A1 (en)
FR (1) FR2888506A1 (en)
IL (1) IL188685A0 (en)
MA (1) MA29729B1 (en)
NO (1) NO20080722L (en)
RU (1) RU2008101268A (en)
TN (1) TNSN08010A1 (en)
WO (1) WO2007006797A1 (en)
ZA (1) ZA200800500B (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2816024B8 (en) * 2006-03-31 2018-04-04 Sunovion Pharmaceuticals Inc. Chiral amines
FR2909283A1 (en) * 2006-11-30 2008-06-06 Cerep Sa COMBINATION PRODUCT CONTAINING N-DESMETHYLSERTRALINE, OR ONE OF ITS SALT, AND AN ANNEOPLASTIC AGENT FOR THE TREATMENT OF CANCER
FR3071726B1 (en) * 2017-09-29 2020-09-04 Univ Paris Sud TCTP PROTEIN INHIBITORS FOR THE TREATMENT OF PROLIFERATIVE AND INFECTIOUS DISEASES

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996022085A1 (en) * 1995-01-17 1996-07-25 Pfizer Inc. The use of sertraline to treat cancer patients
US20050013853A1 (en) * 2000-11-29 2005-01-20 Irit Gil-Ad Anti-proliferative drugs
US20050085477A1 (en) * 2003-08-22 2005-04-21 Pharmacia Corporation Compositions of a cyclooxygenase-2 selective inhibitor and a serotonin-modulating agent for the treatment of neoplasia

Also Published As

Publication number Publication date
WO2007006797A8 (en) 2007-04-19
ZA200800500B (en) 2009-04-29
JP2009501193A (en) 2009-01-15
WO2007006797A1 (en) 2007-01-18
MA29729B1 (en) 2008-09-01
CN101222917A (en) 2008-07-16
TNSN08010A1 (en) 2009-07-14
RU2008101268A (en) 2009-08-20
CA2614696A1 (en) 2007-01-18
NO20080722L (en) 2008-04-04
FR2888506A1 (en) 2007-01-19
EP1904045A1 (en) 2008-04-02
AU2006268657A1 (en) 2007-01-18
KR20080031748A (en) 2008-04-10

Similar Documents

Publication Publication Date Title
HUE059861T2 (en) N-substituted 2,5-dioxo-azoline compounds for use in the treatment of cancer
IL191832A0 (en) Pyridiazinone derivatives for the treatment of tumours
AP2006003525A0 (en) Ä1,8ÜNapthyridin-2-ones and related compounds for the treatment of schizophrenia.
IL206984A0 (en) Analoges of benzoquinone-containing ansamycins for the treatment of cancer
IL208607A0 (en) Improved nanobodiestm for the treatment of aggregation-mediated disorders
PL1984357T3 (en) 2,4-pyrimidinediamine compounds for treating or preventing autoimmune diseases
IL187739A0 (en) New 2-azetidinone derivatives for the treatment of hyperlipidaemic diseases
LT2803366T (en) Compositions for treating or preventing oxalate-related disease
ZA200706697B (en) 3, 4-Substituted pyrrolidine derivatives for the treatment of hypertension
ZA200708575B (en) Methods and compositions for treating or preventing cancer
IL186748A0 (en) 4 - phenyl - 5 - oxo 1, 4, 5, 6, 7, 8 - hexahydroquinoline derivatives for the treatment of infertility
ZA200708033B (en) Tetrahydro-pyridoazepin-8-ones and related compounds for the treatment of schizophrenia
IL187449A0 (en) Variants at chr8q24.21 confer risk of cancer
IL178261A0 (en) Use of 5,10-methylene tetrahydrofolate for the treatment of cancer
PL1945243T3 (en) Use of calcitonin for the treatment of ra
IL188685A0 (en) Use of 4-(3,4-dichloro-phenyl)-1,2,3,4-tetrahydro-naphtalen-1-ylamine for treating cancer
ZA200809565B (en) 4-(2, e-dichloro-benzoylamino)-1H-pyrazole-s-carboxylic acid (1-methanesulphonyl-piperidin-4-yl)-amide for the treatment of cancer
IL187792A0 (en) 4-anilino-3-quinolinecarbonitriles for the treatment of cancer
IL226362A0 (en) Compounds, and methods for the treatment of cancer
GB0517387D0 (en) Combinations for the treatment of cancer
TWI350753B (en) 1-[2h-1-benzopyran-2-one-8-yl]-piperazine derivatives for the treatment of pain
ZA200709959B (en) Triazine compounds and compositions thereof for the treatment of cancers
IL185691A0 (en) Novel compounds derived from 5-thioxylose and therapeutic use thereof
PL1912956T3 (en) Metal salts of 2'-(1h-tetraz0l-5-yl) -1,1'-biphenyl-4-carboxaldehyde
GB0517386D0 (en) Combinations for the treatment of cancer